Importantly, these results of microbial functions might provide beneficial insights into the etiology and development of NKTCL, which implied that the two-way nose-microbiota-UAT NKTCL axis might be a potential target to prevent the development of NKTCL. The gene discussed is SLC22A12; the disease is extranodal nasal NK/T cell lymphoma.